Serum soluble interleukin 2 receptor levels in anti-neutrophil cytoplasmic autoantibodies--positive systemic vasculitis
- PMID: 8255836
- PMCID: PMC2399787
- DOI: 10.1136/pgmj.69.815.708
Serum soluble interleukin 2 receptor levels in anti-neutrophil cytoplasmic autoantibodies--positive systemic vasculitis
Abstract
Systemic vasculitis is characterized by the presence of autoantibodies to neutrophil cytoplasmic antigens (ANCA). The role of T-lymphocytes in systemic vasculitis remains uncertain. In the present study, we attempted to explore the role of T-lymphocytes in systemic vasculitis by measuring the serum soluble interleukin 2 receptor (sIL2R) levels in seven vasculitic patients and comparing the sequential measurements with the titres of ANCA which satisfactorily reflect the disease activity. The serum levels of both ANCA and sIL2R were elevated at clinical presentation. Contrary to ANCA, the serum sIL2R remained elevated in most patients despite clinical remission following immunosuppressive therapy. These findings suggest that T-lymphocytes may be activated in the acute phase of the disease. The finding of elevated serum sIL2R levels in most patients during clinical remission indicates that it is not a good measure of the disease activity and tends to argue against the role of T-lymphocytes as a major effector mediating inflammatory injuries in systemic vasculitis.
Similar articles
-
Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse.Ann Rheum Dis. 2006 Nov;65(11):1484-9. doi: 10.1136/ard.2005.046219. Epub 2006 Feb 27. Ann Rheum Dis. 2006. PMID: 16504995 Free PMC article.
-
T cell activation in patients with ANCA-associated vasculitis: inefficient immune suppression by therapy.Clin Nephrol. 2000 Dec;54(6):435-42. Clin Nephrol. 2000. PMID: 11140803
-
Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies.Am J Kidney Dis. 1993 Sep;22(3):387-92. doi: 10.1016/s0272-6386(12)70140-3. Am J Kidney Dis. 1993. PMID: 8372833
-
ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.J Autoimmun. 1993 Apr;6(2):207-19. doi: 10.1006/jaut.1993.1018. J Autoimmun. 1993. PMID: 8499059 Review.
-
Possible pathogenetic implications of ANCA in vasculitic syndromes.APMIS Suppl. 1990;19:29-30. doi: 10.1111/j.1600-0463.1990.tb05715.x. APMIS Suppl. 1990. PMID: 2285534 Review. No abstract available.
Cited by
-
Cellular aspects of vasculitis--T cell-mediated aspects.Springer Semin Immunopathol. 2001;23(3):287-98. doi: 10.1007/s002810100077. Springer Semin Immunopathol. 2001. PMID: 11591103 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical